LBH589, a novel deacetylase inhibitor (DACI), in the treatment of cutaneous T-cell lymphoma (CTCL): Changes in tumor gene expression profiles related to clinical response after therapy
- Author(s)
- Pan, Y; Prince, HM; George, J; Johnstone, RW; Ellis, L; McCormack, C; Smyth, GK; Williams-Truax, R; Atadja, P; Butterfoss, D; Dugan, M; Culver, K;
- Journal Title
- HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
- Publication Type
- Journal Article
- Publisher
- FERRATA STORTI FOUNDATION
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2007-06-01 12:00:00